Multivariate data analysis easily retrieves insight from a wealth of data - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Multivariate data analysis easily retrieves insight from a wealth of data


Pharmaceutical Technology Europe
Volume 22, Issue 2

Traditionally, studies are performed and analysed following a univariate (one variable at a time) approach. The big advantage of this is that simple 2D plots can be used to assess cause and effect relationships, and the corresponding statistics are straightforward too. The production environment, however, is never univariate, and interactions between parameters should be expected. In the pharmaceutical arena, this situation has been well recognised — guidelines such as ICH Q8 on Pharmaceutical Development and ICH Q10 on Pharmaceutical Quality System explicatively mention the multidimensional design space in which product performance should be tested to assure quality.1,2 In this context, trend analyses of the manufacturing process performance and its products have been mentioned as an important tool for innovation and continuous improvements.3 A potential complicating factor with multidimensional data, however, is that it is not possible to visually inspect such data and so other ways are needed to represent the results.


Matthias Tunger/Getty Images
This is where multivariate statistics can help; it facilitates the powerful analysis of multidimensional data and, simultaneously, amasses knowledge at a single glance.

From dull tables to essential information

For a process running for several years, a wealth of data is usually stored in databases containing continuously measured data and routine-based quality control (QC) data, but it is extremely difficult to obtain useful information from such an intimidating amount of numbers and other data. Multivariate data analysis (MVA) is an approach that converts data into knowledge by using data exploration techniques, without narrowing down solely on allegedly unknown aspects. Representing this knowledge for human interpretation can be done visually.

Historical data can be analysed using MVA to learn from the past, which can be useful to solve current problems, avoid future ones or to make a validation study of a similar production process or compound quicker and cheaper. Analysing historical data can also avoid, or shorten, new studies, which are often expensive. When visualised properly, extended sets of data, such as dull and perhaps confusing tables, can be changed into spatial representations that clearly depict essential information that is not visible a-priori. The methods are widely applicable and can be used, for instance, for measuring the quality and authenticity of samples, or for monitoring a production process.

MVA for a pharmaceutical quality system




MVA helps to transfer data into knowledge, which is very useful in a pharmaceutical quality system, as mentioned in ICH Q10. In this scenario, the analysis of historical data can play an important role: these data are already available and very often contain useful information that can be used for innovation and quality improvement. As this has not yet been commonly recognised, the following case study will demonstrate its advantage.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here